追加説明:
Recipharm has invested heavily in the technology needed to meet worldwide pharmaceutical serialisation and track-and-trace mandates. The company already supplies serialised product to markets including Turkey, South Korea and China, and runs serialisation-capable operations across 15 European sites and more than 70 production lines. Its adaptable standard solution can be tailored to individual client needs, is backed by deep market-requirement expertise, and is offered under a pricing model that avoids large upfront investment.
評価とコメントを残す